Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1978 1
1980 2
1982 1
1983 1
1984 1
1985 1
2001 1
2015 1
2016 4
2017 3
2018 6
2019 5
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Fremanezumab for the Preventive Treatment of Chronic Migraine.
Silberstein SD, Dodick DW, Bigal ME, Yeung PP, Goadsby PJ, Blankenbiller T, Grozinski-Wolff M, Yang R, Ma Y, Aycardi E. Silberstein SD, et al. Among authors: aycardi e. N Engl J Med. 2017 Nov 30;377(22):2113-2122. doi: 10.1056/NEJMoa1709038. N Engl J Med. 2017. PMID: 29171818 Free article. Clinical Trial.
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial.
French JA, Porter RJ, Perucca E, Brodie MJ, Rogawski MA, Pimstone S, Aycardi E, Harden C, Qian J, Rosenblut CL, Kenney C, Beatch GN; X-TOLE Study Group. French JA, et al. Among authors: aycardi e. JAMA Neurol. 2023 Nov 1;80(11):1145-1154. doi: 10.1001/jamaneurol.2023.3542. JAMA Neurol. 2023. PMID: 37812429 Free PMC article. Clinical Trial.
From LBR-101 to Fremanezumab for Migraine.
Bigal ME, Rapoport AM, Silberstein SD, Walter S, Hargreaves RJ, Aycardi E. Bigal ME, et al. Among authors: aycardi e. CNS Drugs. 2018 Nov;32(11):1025-1037. doi: 10.1007/s40263-018-0579-4. CNS Drugs. 2018. PMID: 30311143 Review.
Capturing seizures in clinical trials of antiseizure medications for KCNQ2-DEE.
Millichap JJ, Harden CL, Dlugos DJ, French JA, Butterfield NN, Grayson C, Aycardi E, Pimstone SN. Millichap JJ, et al. Among authors: aycardi e. Epilepsia Open. 2021 Jan 29;6(1):38-44. doi: 10.1002/epi4.12466. eCollection 2021 Mar. Epilepsia Open. 2021. PMID: 33681646 Free PMC article. Review.
Preventive Therapies for Chronic Migraine.
Silberstein SD, Yeung PP, Aycardi E. Silberstein SD, et al. Among authors: aycardi e. N Engl J Med. 2018 Feb 22;378(8):774. doi: 10.1056/NEJMc1716990. N Engl J Med. 2018. PMID: 29466162 No abstract available.
Clinical characteristics and treatment experience of individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE): Findings from an online caregiver survey.
Cutts A, Savoie H, Hammer MF, Schreiber J, Grayson C, Luzon C, Butterfield N, Pimstone SN, Aycardi E, Harden C, Yonan C, Jen E, Nguyen T, Carmack T, Haubenberger D. Cutts A, et al. Among authors: aycardi e. Seizure. 2022 Apr;97:50-57. doi: 10.1016/j.seizure.2022.03.008. Epub 2022 Mar 10. Seizure. 2022. PMID: 35325842 Free article.
30 results